Loading clinical trials...
Loading clinical trials...
The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (BTDS) 20 in comparison to the buprenorphine transdermal system (BTDS) 5 and ox...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Purdue Pharma LP
NCT05492825 · Substance Use Disorders, Chronic Pain, and more
NCT06825390 · Low Back Pain, Chronic Low-back Pain, and more
NCT04893720 · Degenerative Disc Disease, Back Pain Lower Back Chronic, and more
NCT01389999 · Back Pain Lower Back Chronic
NCT07137715 · Chronic Pain, Back Pain, and more
Birmingham Pain Center
Birmingham, Alabama
Arthritis Clinical Intervention Program
Birmingham, Alabama
Winston Physician Services, LLC
Haleyville, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions